Preferred Label : Anti-CD70 Antibody-drug Conjugate SGN-CD70A;
NCIt related terms : SGN-CD70A;
NCIt definition : An antibody-drug conjugate (ADC) containing an engineered cysteine monoclonal antibody
(EC-mAb), directed against the extracellular domain of the human CD70 molecule, conjugated
to the synthetic, cytotoxic, DNA minor-groove crosslinking agent, pyrrolobenzodiazepine
(PBD) dimer, via a stable, protease-cleavable, peptide-based linker, with potential
antineoplastic activity. The anti-CD70 antibody moiety of the anti-CD70 antibody-drug
conjugate SGN-CD70A selectively binds to the extracellular domain of CD70 on tumor
cell surfaces. Upon internalization, the PBD dimer moiety is released and covalently
binds, through its imine moieties, to the N2 positions of guanines on opposite strands
of DNA. This induces DNA double strand breaks and inhibits DNA replication, which
lead to the inhibition of cell growth of tumor cells that overexpress CD70. CD70,
the ligand for the costimulatory receptor CD27 and a member of the tumor necrosis
factor (TNF) family, is found on the surfaces of various types of cancer cells. The
cysteine moiety of the EC-mAb allows for the stable conjugation of the PBD to the
antibody.;
UNII : YFZ7N482WG;
CAS number : 1447736-02-8; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1447736-02-8
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;
Molecule name : SGN-CD70A;
NCI Metathesaurus CUI : CL474127;
Origin ID : C117732;
UMLS CUI : C3896768;
Semantic type(s)
- concept_is_in_subset
